[Lipodystrophia].
Harano
Y
Y
Koshien University College of Nutrition.
D000818:Animals; D002312:Cardiomyopathy, Hypertrophic / Q000209:etiology; D002839:Chromans / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000209:etiology; D003937:Diagnosis, Differential; D005234:Fatty Liver / Q000209:etiology; D006801:Humans; D006946:Hyperinsulinism / Q000209:etiology; D015228:Hypertriglyceridemia / Q000209:etiology; D007333:Insulin Resistance; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use; D050356:Lipid Metabolism; D008060:Lipodystrophy / Q000209:etiology / Q000503:physiopathology; D011379:Prognosis; D013844:Thiazoles / Q000627:therapeutic use; D045162:Thiazolidinediones; D000077288:Troglitazone
D002839:Chromans; D013844:Thiazoles; D045162:Thiazolidinediones; D007334:Insulin-Like Growth Factor I; D000077288:Troglitazone